Astrocytic Chitinase‐3‐like protein 1 in neurological diseases: Potential roles and future perspectives

肌萎缩侧索硬化 多发性硬化 疾病 神经科学 生物标志物 生物 医学 生物信息学 免疫学 病理 遗传学
作者
Fei Li,An Liu,Ming Zhao,Lanxin Luo
出处
期刊:Journal of Neurochemistry [Wiley]
卷期号:165 (6): 772-790 被引量:20
标识
DOI:10.1111/jnc.15824
摘要

Abstract Chitinase‐3‐like protein 1 (CHI3L1) is a secreted glycoprotein characterized by its ability to regulate multiple biological processes, such as the inflammatory response and gene transcriptional signaling activation. Abnormal CHI3L1 expression has been associated with multiple neurological disorders and serves as a biomarker for the early detection of several neurodegenerative diseases. Aberrant CHI3L1 expression is also reportedly associated with brain tumor migration and metastasis, as well as contributions to immune escape, playing important roles in brain tumor progression. CHI3L1 is synthesized and secreted mainly by reactive astrocytes in the central nervous system. Thus, targeting astrocytic CHI3L1 could be a promising approach for the treatment of neurological diseases, such as traumatic brain injury, ischemic stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, and glioma. Based on current knowledge of CHI3L1, we assume that it acts as a molecule mediating several signaling pathways driving the initiation and progression of neurological disorders. This narrative review is the first to introduce the potential roles of astrocytic CHI3L1 in neurological disorders. We also equally explore astrocytic CHI3L1 mRNA expression under physiological and pathological conditions. Inhibiting CHI3L1 and disrupting its interaction with its receptors through multiple mechanisms of action are briefly discussed. These endeavors highlight the pivotal roles of astrocytic CHI3L1 in neurological disorders and could contribute to the development of effective inhibitors based on the strategy of structure‐based drug discovery, which could be an attractive therapeutic approach for neurological disease treatment. image
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
大橙子发布了新的文献求助10
2秒前
量子星尘发布了新的文献求助10
3秒前
jenny完成签到,获得积分10
4秒前
祁乐安完成签到,获得积分10
5秒前
naiyouqiu1989完成签到,获得积分10
6秒前
zjhzslq发布了新的文献求助10
7秒前
baoxiaozhai完成签到 ,获得积分10
8秒前
fy完成签到,获得积分10
9秒前
强公子完成签到,获得积分10
10秒前
16秒前
song完成签到 ,获得积分10
17秒前
怡然小蚂蚁完成签到 ,获得积分10
17秒前
小橙子完成签到,获得积分10
19秒前
SciGPT应助滴答采纳,获得10
19秒前
大气白翠完成签到,获得积分10
20秒前
确幸完成签到,获得积分10
20秒前
zjhzslq完成签到,获得积分10
20秒前
xdc发布了新的文献求助10
21秒前
ommphey完成签到 ,获得积分10
21秒前
牛哥还是强啊完成签到 ,获得积分10
22秒前
科研通AI2S应助屈岂愈采纳,获得10
23秒前
好名字完成签到,获得积分10
24秒前
kongzhiqiqi完成签到,获得积分10
25秒前
滴答完成签到 ,获得积分10
25秒前
浅浅殇完成签到,获得积分10
29秒前
30秒前
32秒前
滴答发布了新的文献求助10
35秒前
高高的天亦完成签到 ,获得积分10
36秒前
星空完成签到 ,获得积分10
37秒前
文艺的青旋完成签到 ,获得积分10
37秒前
青黛完成签到 ,获得积分10
44秒前
大橙子发布了新的文献求助10
48秒前
领导范儿应助科研通管家采纳,获得10
49秒前
量子星尘发布了新的文献求助10
53秒前
明钟达完成签到 ,获得积分10
1分钟前
byyyy完成签到,获得积分10
1分钟前
高高的哈密瓜完成签到 ,获得积分10
1分钟前
Rondab应助橙汁采纳,获得10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022